Murray Stahl’s Apyx Medical APYX Stock Holding History

Murray Stahl’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.63M	Sell	585,000 -30,000	-5%	-$119K	0.03%	102
2026 Q1	$2.27M	Hold	615,000	–	–	0.02%	110
2025 Q4	$2.15M	Hold	615,000	–	–	0.03%	111
2025 Q3	$1.32M	Hold	615,000	–	–	0.02%	149
2025 Q2	$1.38M	Hold	615,000	–	–	0.02%	154
2025 Q1	$843K	Hold	615,000	–	–	0.01%	191
2024 Q4	$972K	Hold	615,000	–	–	0.01%	179
2024 Q3	$763K	Hold	615,000	–	–	0.01%	204
2024 Q2	$824K	Hold	615,000	–	–	0.01%	177
2024 Q1	$836K	Hold	615,000	–	–	0.02%	177
2023 Q4	$1.61M	Hold	615,000	–	–	0.03%	113
2023 Q3	$1.97M	Hold	615,000	–	–	0.04%	98
2023 Q2	$3.09M	Hold	615,000	–	–	0.07%	78
2023 Q1	$1.77M	Hold	615,000	–	–	0.03%	109
2022 Q4	$1.44M	Hold	615,000	–	–	0.02%	122
2022 Q3	$2.76M	Hold	615,000	–	–	0.06%	77
2022 Q2	$3.6M	Hold	615,000	–	–	0.08%	72
2022 Q1	$4.02M	Hold	615,000	–	–	0.08%	78
2021 Q4	$7.88M	Hold	615,000	–	–	0.17%	63
2021 Q3	$8.52M	Hold	615,000	–	–	0.2%	55
2021 Q2	$6.34M	Hold	615,000	–	–	0.13%	69
2021 Q1	$5.94M	Hold	615,000	–	–	0.13%	56
2020 Q4	$4.43M	Hold	615,000	–	–	0.15%	59
2020 Q3	$2.9M	Hold	615,000	–	–	0.12%	83
2020 Q2	$3.41M	Hold	615,000	–	–	0.12%	70
2020 Q1	$2.21M	Hold	615,000	–	–	0.1%	83
2019 Q4	$5.2M	Hold	615,000	–	–	0.15%	55
2019 Q3	$4.16M	Hold	615,000	–	–	0.13%	63
2019 Q2	$4.13M	Hold	615,000	–	–	0.11%	70
2019 Q1	$3.88M	Buy	+615,000	New	+$4.76M	0.11%	74

Other funds holding APYX

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Murray Stahl's APYX Position: Q2 2026 in Review

Murray Stahl reduced its Apyx Medical (APYX) stake by 4.9% in Q2 2026, selling an estimated $119K and leaving 585,000 shares worth $2.63M. The position accounts for 0.03% of the portfolio, ranked #102.

Murray Stahl first reported a position in APYX in Q1 2019 and has held it in 30 quarters since. The position peaked at $8.52M in Q3 2021. 68 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

Murray Stahl held 585,000 shares of Apyx Medical worth $2.63M as of Q2 2026.
Murray Stahl sold 30,000 Apyx Medical shares in Q2 2026, an estimated $119K.
Apyx Medical made up 0.03% of Murray Stahl's portfolio in Q2 2026, its #102 holding.
Murray Stahl first reported a position in Apyx Medical in Q1 2019 and has held it in 30 quarters since.
Murray Stahl's Apyx Medical position peaked at $8.52M in Q3 2021.
68 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on Horizon Kinetics Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.